Moreover, previous work has shown that inhibition of NF-κB signaling alleviates inflammation and restores Treg/Th17 balance in various immune-mediated disease models, such as sepsis-induced lung injury and asthma (47, 48). The gene discussed is NFKB1; the disease is injury.